Company News in the Life Science Industry

»

Reset 

Impel NeuroPharma Announces Appointment of Sheena K. Aurora, MD, As Vice President of Medical Affairs - Migraine Franchise

SEATTLE, Jan. 16, 2020 /PRNewswire/ -- Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announced the appointment... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  Impel NeuroPharma, Inc.

Access Living Names Commissioner Karen Tamley of the Chicago Mayor's Office for People with Disabilities Its Next CEO

CHICAGO, Jan. 16, 2020 /PRNewswire/ -- Access Living's Board of Directors today announced that Karen Tamley has been named the next... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

Pulmatrix Regains Compliance with Nasdaq Minimum Bid Price Requirement

LEXINGTON, Mass., Jan. 16, 2020 /PRNewswire/ -- Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  Pulmatrix, Inc.

Global physiotherapy equipment market is expected to grow with a CAGR of 5.6% over the forecast period from 2019-2025

NEW YORK, Jan. 16, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2020

Global transdermal drug delivery system market is expected to grow with a CAGR of 4.3% over the forecast period from 2019-2025

NEW YORK, Jan. 16, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2020

Global Laboratory Filtration Market Study, Forecast to 2025 with Analysis by Product, Technology, End-user and Region

DUBLIN, Jan. 16, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

NORD Issues a Rare Decree: Show Your Stripes(TM) for Rare Disease Day®

WASHINGTON, Jan. 16, 2020 /PRNewswire/ -- The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing over 25 million Americans living with rare diseases, is issuing a Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

$3.9Bn Oligonucleotide Synthesis Industry Analysis, 2019-2025

DUBLIN, Jan. 16, 2020 The Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020

Telehealth saves unborn children in Maryland

MCLEAN, Va., Jan. 16, 2020 /PRNewswire/ -- A woman in her eighth month of pregnancy enters a clinic for her routine checkup. During the sonogram, the clinician suspects a fetal heart abnormality. She immediately requests a consult with a pediatric cardiologist at a nearby hospital. Within minutes,... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  ViTel Net

Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2019 Financial Results on February 19

LAVAL, Quebec, Jan. 16, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") will release its fourth-quarter and full-year 2019 financial results on Wednesday, Feb. 19, 2020. Bausch Health will host a conference call and live web cast at 8:00 a.m. ET to discuss... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  Bausch Health Companies Inc.

InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

VANCOUVER, Jan. 16, 2020 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that members of its senior scientific... Read more ››

By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  InMed Pharmaceuticals Inc.

University Health Network Completes Validation of SQI Diagnostics' TORdx LUNG(TM) Organ Assessment Assay

Major milestone in commercialization of precision medicine technology achieved

Read more ››
By: PR Newswire Association LLC. - 16 Jan 2020
Related companies:  SQI Diagnostics Inc.

Nicox’s Partner Secures Additional Approvals of VYZULTA (latanoprostene bunod ophthalmic solution), 0.024% in Hong Kong and Argentina

Read more ››
By: GlobenewsWire - 16 Jan 2020
Related companies:  Nicox S.A.

Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People

Read more ››
By: GlobenewsWire - 16 Jan 2020
Related companies:  Novan, Inc.

ViaDerma, Inc. Provides a Corporate Update

Read more ››
By: GlobenewsWire - 16 Jan 2020

Managers' transactions

Read more ››
By: GlobenewsWire - 16 Jan 2020

CoImmune Inc., a US-based clinical-stage biotech, and Formula Pharmaceutical Inc. agree to merge in an all-stock transaction

Read more ››
By: GlobenewsWire - 16 Jan 2020

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday January 21, 2020 at 9:30 AM

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Generex Biotechnology Corp. | Genovior Biotech Corporation

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  DBV Technologies S.A.

GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome

Read more ››
By: GlobenewsWire - 15 Jan 2020
Related companies:  Ultragenyx Pharmaceutical Inc.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies